QF MED QF SALAS - CPSP 221 TO 224 OF 2026

This tender concerns the provision of specialized professional services to support the Group for Support of Specialized Chambers of the Review Commission of the Directorate of Medicines and Biological Products of INVIMA. The contract, references CPSP 221 to 224 of 2026, is for a duration of 10 months and is being procured through direct contracting. The services involve preparing pre-concepts and conducting pre-clinical and clinical studies for the modification of pharmacological information related to indications, routes of administration, posology, and changes in sales conditions. These assessments are submitted for consideration by the Review Commission. The role also includes conducting accompanying analyses. The objective is to ensure that all modifications to drug information are rigorously evaluated for safety and efficacy before approval, upholding INVIMA's mandate to protect public health. The specialized professionals will provide critical technical and scientific input to the review process, contributing to the safe and effective use of medicines in Colombia. This procurement is vital for INVIMA's regulatory functions.

This is a services contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals and Laboratories. Located in Colombia, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of COP 97.8 million.

Published through SECOP II Colombia (Date-Filtered), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.